Purpose
to analyze the nature of improved neutralizing anti-HIV antibody responses obtained with the 3M-052 adjuvant; learnings will be applied to further improve antibody responses in future HIV vaccine studies
Grantee
Division
Global Health
Date
NOVEMBER 2019
Region served
AMERICA
Committed amount
$370,667
Grant topic
HIV
Duration (months)
41
Grantee location
Redwood City, California, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.